Prices Prices Prices
The Vital Health Care Shift Nobody Is Talking About
show comments
  • Fat_Man

    Looking for medical care developments nobody is talking about? Here is one:

    “This Woman Invented a Way to Run 30 Lab Tests on Only One Drop of Blood” By Caitlin Roper 02.18.14
    http://www.wired.com/wiredscience/2014/02/elizabeth-holmes-theranos/

    [At age 19, Elizabeth] Holmes, now 30, dropped out of Stanford and founded a company called Theranos with her tuition money. … Instead of vials of blood—one for every test needed—Theranos requires only a pinprick and a drop of blood. With that they can perform hundreds of tests, from standard cholesterol checks to sophisticated genetic analyses. The results are faster, more accurate, and far cheaper than conventional methods. … The company plans to charge less than 50 percent of the standard Medicare and Medicaid reimbursement rates. And unlike the rest of the testing industry, Theranos lists its prices on its website … If all tests in the US were performed at those kinds of prices, the company says, it could save Medicare $98 billion and Medicaid $104 billion over the next decade.”

    Eric J. Topol, M.D., the author of “The Creative Destruction of Medicine: How the Digital Revolution Will Create Better Health Care” is editor-in-chief of Medscape.com. He is also Director of Scripps Translational Science Institute, professor of genomics at The Scripps Research Institute and Chief Academic Officer of Scripps Health. Before that he was chairman of cardiovascular medicine at the Cleveland Clinic and founder of the Cleveland Clinic Lerner College of Medicine. He wrote “Topol Reviews 2013: A Year of Revolutionizing Medicine” by Eric J. Topol, MD, http://www.medscape.com/viewarticle/817648:

    “We send our patients to the clinic or hospital lab, or a central facility, to get their blood drawn. Typically, multiple tubes of blood are obtained; the costs are not transparent; and perhaps even worse, the results are not easily or routinely accessible for most patients. Last month, I highlighted a new entity on the scene — Theranos — and interviewed Elizabeth Holmes, the young CEO. Theranos will be in all Walgreens stores before long, leveraging microfluidic technology to do hundreds of assays with a droplet of blood, with a fully transparent cost list, and ultimately with results directly going to both the patient and doctor. After 60 years of unchanged laboratory medicine practice, this new, innovative model will help drive disruption — just the kind of shake-up that we have needed. ”

    Here is a link to the interview:

    http://www.medscape.com/viewarticle/814233

  • Anthony

    “Economists marvel at our health care sector and its ability to deliver less for more…the United States spends absolutely more per-capita, and more as a percentage of GDP, by a considerable amount. We have been spending more than one-sixth of GDP on health care…Per capita spending in the United States has been two and a half times higher than the average of the advanced industrial countries…While there are many reasons for this disparity in the efficiency of the health care system, rent seeking, in particular on the part of health insurance companies and drug companies, play a significant role.”

© The American Interest LLC 2005-2017 About Us Masthead Submissions Advertise Customer Service
We are a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for us to earn fees by linking to Amazon.com and affiliated sites.